Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and … Read more
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Asset Resilience Ratio
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) has an Asset Resilience Ratio of 15.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥158.56 Million | 15.06% |
| Total Liquid Assets | CN¥158.56 Million | 15.06% |
Asset Resilience Insights
- Good Liquidity Position: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd maintains a healthy 15.06% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.99% | CN¥84.93 Million | CN¥1.06 Billion | -12.24pp |
| 2023-12-31 | 20.23% | CN¥215.91 Million | CN¥1.07 Billion | -20.39pp |
| 2022-12-31 | 40.63% | CN¥413.17 Million | CN¥1.02 Billion | +29.69pp |
| 2021-12-31 | 10.93% | CN¥65.00 Million | CN¥594.61 Million | -- |